Kazia Therapeutics Ltd
KZIA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001075880
No open-market purchases or sales by Kazia Therapeutics Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $50.7M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +12 vs. previous quarter
- 35
- 13F valueReported value at the end of Q2 2026
- $50.7M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding KZIA, Q2 2026
No superinvestor reported holding KZIA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Kazia Therapeutics Ltd insiders from Form 4, newest first.
No open-market purchases or sales by Kazia Therapeutics Ltd insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Kazia Therapeutics Ltd at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Boxer Capital Management, LLC | 560,000 | $7.88M | 0.59% | +560,000 | New |
| Flputnam Investment Management Co | 414,958 | $5.84M | 0.07% | +272,489+191.3% | Added |
| Bleichroeder LP | 400,000 | $5.63M | 1.01% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 396,201 | $5.58M | 0.91% | +396,201 | New |
| Dauntless Investment Group, LLC | 354,208 | $4.99M | 8.65% | +274,376+343.7% | Added |
| Stonepine Capital Management, LLC | 345,179 | $4.86M | 3.70% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 200,300 | $2.30M | 0.00% | +300+0.2% | Added |
| Ensign Peak Advisors, Inc | 110,778 | $1.56M | 0.00% | +110,778 | New |
| Millennium Management LLC | 101,376 | $1.43M | 0.00% | +101,376 | New |
| UBS Group AG | 81,090 | $1.14M | 0.00% | +67,156+482.0% | Added |